Related references
Note: Only part of the references are listed.Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors
Vanangamudi Murugesan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Graph Theory Concepts in the Rationales of Anti HIV-1 Compounds
Utsab Debnath et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2013)
Structure-Activity Relationship Studies on Clinically Relevant HIV-1 NNRTIs
R. K. Rawal et al.
CURRENT MEDICINAL CHEMISTRY (2012)
HIV-1 Antiretroviral Drug Therapy
Eric J. Arts et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors
Vanangamudi Murugesan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
Erik De Clercq
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents
Vanangamudi Murugesan et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2009)
2-(2,6-dihalo-phenyl)-3-heteroaryl-2-ylmethyl-1, 3-thiazolidin-4-ones: Anti-HIV agents
Ravindra K. Rawal et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
The design of drugs for HIV and HCV
Erik De Clercq
NATURE REVIEWS DRUG DISCOVERY (2007)
HIV-1 reverse transcriptase inhibitors
Yazan El Safadi et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents
Ravindra K. Rawal et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Scalable molecular dynamics with NAMD
JC Phillips et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Synthesis and QSAR studies on thiazolidinones as anti-HIV agents
RK Rawal et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2005)
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors
A Rao et al.
ANTIVIRAL RESEARCH (2004)
New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections
R Pauwels
CURRENT OPINION IN PHARMACOLOGY (2004)
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): Past, present, and future
E De Clercq
CHEMISTRY & BIODIVERSITY (2004)
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents
ML Barreca et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
